Timothy J. Hagen - Concepedia

Author

Timothy J. Hagen

University of Wisconsin–Milwaukee ORCID

Also Known As

Cotter, Peggy A., Hagen, T.J., T Hagen, T J Hagen, T. HAGEN, T. Hagen, T. J. HAGEN, T. J. Hagen, T.J. Hagen, Tim Hagen

109

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

University of Wisconsin–Milwaukee Northern Illinois University Center for Infectious Disease Research Beryllium (United States)

About

Timothy J. Hagen is an author at University of Wisconsin–Milwaukee specializing in pharmacology, medicine, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	24	1.2K
2	Natural Sciences	13	14	566
3	Health Sciences	4	4	130
4	Engineering	3	3	80
5	Social Sciences	3	3	63

Timothy J. Hagen

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety Alex B. Burgin, Ólafur Þ. Magnússon, Jasbir Singh, Nature Biotechnology MedicineNeuropharmacologyNeurosciencePharmacologyPhosphodiesterase 4D	2009	391
Synthetic and computer-assisted analyses of the pharmacophore for the benzodiazepine receptor inverse agonist site M.S. Allen, Mark L. Trudell, Timothy J. Hagen, Journal of Medicinal Chemistry	1990	122
Hyperglycemia and Hemorrhagic Transformation of Cerebral Infarcts Joseph P. Broderick, Timothy J. Hagen, Thomas G. Brott, Stroke	1995	97
Synthesis of novel 3-substituted .beta.-carbolines as benzodiazepine receptor ligands: probing the benzodiazepine receptor pharmacophore M.S. Allen, Timothy J. Hagen, Mark L. Trudell, Journal of Medicinal Chemistry	1988	83
Design and Synthesis of Selective Phosphodiesterase 4D (PDE4D) Allosteric Inhibitors for the Treatment of Fragile X Syndrome and Other Brain Disorders Mark E. Gurney, Richard A. Nugent, Xuesheng Mo, Journal of Medicinal Chemistry Drug TargetEarlier Pde4 InhibitorsLead IdentificationAllosteric InhibitorsChemical Biology	2019	73
N-Substituted dibenzoxazepines as analgesic PGE2 antagonists E. Ann Hallinan, Timothy J. Hagen, Robert K. Husa, Journal of Medicinal Chemistry Pain MedicineEp1 Receptor SubtypePharmacotherapyPharmaceutical ChemistryMolecular Pharmacology	1993	72
DDQ oxidations in the indole area. Synthesis of 4-alkoxy-.beta.-carbolines including the natural products crenatine and 1-methoxycanthin-6-one Timothy J. Hagen, Narayanan Krishnaswamy, Jeffrey Names, The Journal of Organic Chemistry Ddq OxidationsBioorganic ChemistryBiochemistryNatural SciencesNatural Products Crenatine	1989	65
Aminoacetyl Moiety as a Potential Surrogate for Diacylhydrazine Group of SC-51089, a Potent PGE<sub>2</sub> Antagonist, and Its Analogs E. Ann Hallinan, Timothy J. Hagen, Sofya Tsymbalov, Journal of Medicinal Chemistry Drug TargetEp1 Receptor SubtypePharmacotherapyChemical BiologyPharmaceutical Chemistry	1996	64
2-Iminopyrrolidines as Potent and Selective Inhibitors of Human Inducible Nitric Oxide Synthase Timothy J. Hagen, Arija A. Bergmanis, Steven W. Kramer, Journal of Medicinal Chemistry	1998	60
Synthetic and computer assisted analysis of the pharmacophore for agonists at benzodiazepine receptors Hernando Díaz-Araúzo, Konrad F. Koehler, Timothy J. Hagen, Life Sciences Medicinal ChemistryDrug TargetBiochemistryFunctional SelectivityMedicine	1991	56

Page 1